Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Nanoethics Group is a non-partisan research and educational organization focused on the social and ethical implications of nanotechnology and other emerging technologies. Founded by Dr. Patrick Lin, the group provides analysis, consulting, and public outreach regarding the risks and benefits of nanotech, including its applications in medicine, military, and industry. Their work aims to guide policy-makers, organizations, and the public in navigating the complex ethical landscape of technological advancement. The group is recognized for its contributions to the governance of nanomedicine, human enhancement technologies, and environmental safety. They have collaborated with major institutions such as the National Science Foundation to produce foundational reports on the future of nanotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanoethics Group.